BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 8283030)

  • 1. Role of B cells in antigen presentation of the hepatitis B core.
    Milich DR; Chen M; Schödel F; Peterson DL; Jones JE; Hughes JL
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14648-53. PubMed ID: 9405667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the hepatitis B core antigen and the innate immune system.
    Lee BO; Tucker A; Frelin L; Sallberg M; Jones J; Peters C; Hughes J; Whitacre D; Darsow B; Peterson DL; Milich DR
    J Immunol; 2009 Jun; 182(11):6670-81. PubMed ID: 19454661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral-Oral Immunization with Plant-Derived HBcAg as a Potential Therapeutic Vaccine against Chronic Hepatitis B.
    Pyrski M; Mieloch AA; Plewiński A; Basińska-Barczak A; Gryciuk A; Bociąg P; Murias M; Rybka JD; Pniewski T
    Vaccines (Basel); 2019 Dec; 7(4):. PubMed ID: 31835350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic switching of hepatitis B virus by alternative dimerization of the capsid protein.
    DiMattia MA; Watts NR; Stahl SJ; Grimes JM; Steven AC; Stuart DI; Wingfield PT
    Structure; 2013 Jan; 21(1):133-142. PubMed ID: 23219881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute Quantification of Hepatitis B Core Antigen (HBcAg) Virus-like Particles and Bound Nucleic Acids.
    Valentic A; Böhner N; Hubbuch J
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38275948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter-regulated
    Chen C; Zhou J; Men D; Zhang XE
    Nanoscale; 2022 Nov; 14(43):16180-16184. PubMed ID: 36278831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Model Systems for Hepatitis B Virus Research.
    Ortega-Prieto AM; Cherry C; Gunn H; Dorner M
    ACS Infect Dis; 2019 May; 5(5):688-702. PubMed ID: 30539633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse models for hepatitis B virus research.
    Hwang JR; Park SG
    Lab Anim Res; 2018 Sep; 34(3):85-91. PubMed ID: 30310404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.
    Teng YC; Shen ZQ; Kao CH; Tsai TF
    World J Gastroenterol; 2016 Jan; 22(1):300-25. PubMed ID: 26755878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions.
    Inuzuka T; Takahashi K; Chiba T; Marusawa H
    Pathogens; 2014 Apr; 3(2):377-89. PubMed ID: 25437805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cellular proteasome activities mediates HBX-independent hepatitis B virus replication in vivo.
    Zhang Z; Sun E; Ou JH; Liang TJ
    J Virol; 2010 Sep; 84(18):9326-31. PubMed ID: 20592087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental models of hepatocellular carcinoma: developments and evolution.
    Wu L; Tang ZY; Li Y
    J Cancer Res Clin Oncol; 2009 Aug; 135(8):969-81. PubMed ID: 19399516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune tolerance split between hepatitis B virus precore and core proteins.
    Chen M; Sällberg M; Hughes J; Jones J; Guidotti LG; Chisari FV; Billaud JN; Milich DR
    J Virol; 2005 Mar; 79(5):3016-27. PubMed ID: 15709022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nondeletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection.
    Chen M; Sällberg M; Thung SN; Hughes J; Jones J; Milich DR
    J Virol; 2000 Aug; 74(16):7587-99. PubMed ID: 10906213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens.
    Sällberg M; Townsend K; Chen M; O'Dea J; Banks T; Jolly DJ; Chang SM; Lee WT; Milich DR
    J Virol; 1997 Jul; 71(7):5295-303. PubMed ID: 9188598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
    Milich DR; Schödel F; Hughes JL; Jones JE; Peterson DL
    J Virol; 1997 Mar; 71(3):2192-201. PubMed ID: 9032353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level hepatitis B virus replication in transgenic mice.
    Guidotti LG; Matzke B; Schaller H; Chisari FV
    J Virol; 1995 Oct; 69(10):6158-69. PubMed ID: 7666518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice.
    Milich DR; Jones JE; Hughes JL; Maruyama T; Price J; Melhado I; Jirik F
    J Immunol; 1994 Jan; 152(2):455-66. PubMed ID: 8283030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice.
    Takashima H; Araki K; Miyazaki J; Yamamura K; Kimoto M
    Immunology; 1992 Mar; 75(3):398-405. PubMed ID: 1533387
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.